|DBV Technologies S A -- USA Stock|| |
USD 23.41 1.10 4.49%
Co-Founder and Sr. Executive VP of Technology
Mr. Bertrand Dupont is Industrial Director of DBV Technologies SA. He is also the cofounder of the Company. Prior to cofounding DBV Technologies, Mr. Dupont qualified as an engineer from the Ecole Nationale Superieure des Arts et Metiers in Paris and went on to pursue a career in teaching and consultancy. From 1996, Mr. Dupont worked in biomedical research and from 2000 was involved in the development of VIASKIN patch technology and application system.
Age: 64 Founder Since 2013
33 1 55 42 78 78 http://www.dbv-technologies.com
The company has return on total asset (ROA)
of (30.43) %
which means that it has lost $30.43 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE)
of (57.09) %
meaning that it created substantial loss on money invested by shareholders.
The company currently holds 5.54 M in liabilities with Debt to Equity (D/E) ratio of 2.3 implying the company greatly relies on financing operations through barroing. DBV Technologies S A has Current Ratio of 6.62 suggesting that it is liquid enough and is able to pay its financial obligations when they are due.
DBV Technologies S.A., a clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products. DBV Technologies S.A. was founded in 2002 and is headquartered in Montrouge, France. DBV Technologies is traded on NASDAQ in USA.DBV Technologies S A (DBVT) is traded on NASDAQ in USA. It is located in FRANCE and employs 192 people. DBV Technologies is listed under Pharmaceutical Products category by Fama And French industry classification.